docetaxel,sotorasib
amgen
['lcsm,(-blcsm)', 'codebreak 200', 'sotorasib']
in time, patients that received sotorasib in codebreak 200 were more prone to derive long term response. notch1 mutations seem to demonstrate resistance to sotorasib and a larger benefit from doce. #asco23 #lcsm 
Husband, Father. Medical Oncologist and Researcher focused in Thoracic Oncology.  Views are my own. Member of @latenightonc - the best podcast in oncology!